Researchers outlined nine regulatory research-related challenges to validating, advancing, and improving next-generation sequencing-based diagnostic tests.
"I'm on this planet thanks to being an early prototype of precision medicine myself," said Eric Dishman, who the NIH has picked to lead the PMI Cohort Program.
Since the PMI will take some time and more funds to implement, experts believe legislation is needed to ensure the project has continued support.
The company intends to provide no-cost subscriptions to the Cloudera platform for storage, processing, and analyzing big data to researchers at some 50 institutions.
Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.
The agency is asking for input on conducting baseline physical evaluations of program volunteers and for obtaining biospecimens from these individuals.
The agency also said it will commit up to $15.8 million in fiscal 2016 for programs advancing tools and technologies in support of its ongoing BRAIN Initiative.
23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.
He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.
Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.
In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.